Form 4 for CRSP CRISPR Therapeutics AG
Accepted 2026-01-26 00:00:00 ET · period of report 2026-01-22 · accession 0001193125-26-022845 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-01-26 | 2026-01-22 | CRSP | Prasad Raju | CFO | M - OptEx | $45.15 | +35.0K | 41.7K | +517% | +$1.58M |
| DT | 2026-01-26 | 2026-01-22 | CRSP | Prasad Raju | CFO | S - Sale+OE | $60.19 | -35.0K | 6,767 | -84% | -$2.10M |
| DT | 2026-01-26 | 2026-01-22 | CRSP | Prasad Raju | CFO | M - OptEx | $0.00 | -35.0K | 41.7K | -46% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2026-01-22 | M | A | 34,972 | $45.15 | 41,739 | D | — | — | |
| 2 | Common | Common Shares | 2026-01-22 | S | D | 34,972 | $60.19 | 6,767 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-01-22 | M | D | 34,972 | $0.00 | 41,667 | D | $45.15 · — to 2033-03-14 | 34,972 Common Shares | (F3) This option was granted on March 14, 2023 with respect to 100,000 Common Shares, with 25% of the shares vesting on March 14, 2024 and the remaining shares vesting on each monthly anniversary thereafter for a period of 36 months. |